3,4-Fused cyclohexyl sulfones as gamma-secretase inhibitors. 2006

Duncan Shaw, and Jonathan Best, and Kevin Dinnell, and Alan Nadin, and Mark Shearman, and Christine Pattison, and James Peachey, and Michael Reilly, and Brian Williams, and Jonathan Wrigley, and Timothy Harrison
Department of Medicinal Chemistry, Neuroscience Research Centre, Terlings Park, Eastwick Road, Harlow, Essex CM20 2QR, UK. Duncan_shaw@merck.com

The 3,4-fused sulfamides, sulfonamides and sulfone have been identified as highly potent gamma-secretase inhibitors. Evaluation of the SAR of substitution within these series has allowed the identification of a range of compounds which significantly reduce brain A beta in transgenic mouse models and thus have potential as possible treatments for Alzheimer's disease.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D010450 Endopeptidases A subclass of PEPTIDE HYDROLASES that catalyze the internal cleavage of PEPTIDES or PROTEINS. Endopeptidase,Peptide Peptidohydrolases
D011480 Protease Inhibitors Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). Antiprotease,Endopeptidase Inhibitor,Endopeptidase Inhibitors,Peptidase Inhibitor,Peptidase Inhibitors,Peptide Hydrolase Inhibitor,Peptide Hydrolase Inhibitors,Peptide Peptidohydrolase Inhibitor,Peptide Peptidohydrolase Inhibitors,Protease Antagonist,Protease Antagonists,Antiproteases,Protease Inhibitor,Antagonist, Protease,Antagonists, Protease,Hydrolase Inhibitor, Peptide,Hydrolase Inhibitors, Peptide,Inhibitor, Endopeptidase,Inhibitor, Peptidase,Inhibitor, Peptide Hydrolase,Inhibitor, Peptide Peptidohydrolase,Inhibitor, Protease,Inhibitors, Endopeptidase,Inhibitors, Peptidase,Inhibitors, Peptide Hydrolase,Inhibitors, Peptide Peptidohydrolase,Inhibitors, Protease,Peptidohydrolase Inhibitor, Peptide,Peptidohydrolase Inhibitors, Peptide
D003500 Cyclization Changing an open-chain hydrocarbon to a closed ring. (McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Cyclizations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013450 Sulfones Sulfone
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D016282 Aspartic Acid Endopeptidases A sub-subclass of endopeptidases that depend on an ASPARTIC ACID residue for their activity. Aspartic Endopeptidases,Aspartyl Endopeptidases,Acid Endopeptidases, Aspartic,Endopeptidases, Aspartic Acid,Endopeptidases, Aspartyl
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

Duncan Shaw, and Jonathan Best, and Kevin Dinnell, and Alan Nadin, and Mark Shearman, and Christine Pattison, and James Peachey, and Michael Reilly, and Brian Williams, and Jonathan Wrigley, and Timothy Harrison
May 2005, Bioorganic & medicinal chemistry letters,
Duncan Shaw, and Jonathan Best, and Kevin Dinnell, and Alan Nadin, and Mark Shearman, and Christine Pattison, and James Peachey, and Michael Reilly, and Brian Williams, and Jonathan Wrigley, and Timothy Harrison
June 2010, Bioorganic & medicinal chemistry letters,
Duncan Shaw, and Jonathan Best, and Kevin Dinnell, and Alan Nadin, and Mark Shearman, and Christine Pattison, and James Peachey, and Michael Reilly, and Brian Williams, and Jonathan Wrigley, and Timothy Harrison
June 2010, Bioorganic & medicinal chemistry letters,
Duncan Shaw, and Jonathan Best, and Kevin Dinnell, and Alan Nadin, and Mark Shearman, and Christine Pattison, and James Peachey, and Michael Reilly, and Brian Williams, and Jonathan Wrigley, and Timothy Harrison
April 2010, Bioorganic & medicinal chemistry letters,
Duncan Shaw, and Jonathan Best, and Kevin Dinnell, and Alan Nadin, and Mark Shearman, and Christine Pattison, and James Peachey, and Michael Reilly, and Brian Williams, and Jonathan Wrigley, and Timothy Harrison
April 2004, Bioorganic & medicinal chemistry letters,
Duncan Shaw, and Jonathan Best, and Kevin Dinnell, and Alan Nadin, and Mark Shearman, and Christine Pattison, and James Peachey, and Michael Reilly, and Brian Williams, and Jonathan Wrigley, and Timothy Harrison
January 2007, Bioorganic & medicinal chemistry letters,
Duncan Shaw, and Jonathan Best, and Kevin Dinnell, and Alan Nadin, and Mark Shearman, and Christine Pattison, and James Peachey, and Michael Reilly, and Brian Williams, and Jonathan Wrigley, and Timothy Harrison
October 2007, Bioorganic & medicinal chemistry letters,
Duncan Shaw, and Jonathan Best, and Kevin Dinnell, and Alan Nadin, and Mark Shearman, and Christine Pattison, and James Peachey, and Michael Reilly, and Brian Williams, and Jonathan Wrigley, and Timothy Harrison
November 2007, Bioorganic & medicinal chemistry letters,
Duncan Shaw, and Jonathan Best, and Kevin Dinnell, and Alan Nadin, and Mark Shearman, and Christine Pattison, and James Peachey, and Michael Reilly, and Brian Williams, and Jonathan Wrigley, and Timothy Harrison
December 2011, Nihon rinsho. Japanese journal of clinical medicine,
Duncan Shaw, and Jonathan Best, and Kevin Dinnell, and Alan Nadin, and Mark Shearman, and Christine Pattison, and James Peachey, and Michael Reilly, and Brian Williams, and Jonathan Wrigley, and Timothy Harrison
August 2002, Molecular neurobiology,
Copied contents to your clipboard!